ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: TH-PO267

Arteriovenous-Oscillometry to Assess Fistula Function

Session Information

Category: Dialysis

  • 703 Dialysis: Vascular Access


  • Busch, Veit, Fachhochschule Dortmund, Dortmund, Nordrhein-Westfalen, Germany
  • Streis, Joachim, Fachhochschule Dortmund, Dortmund, Nordrhein-Westfalen, Germany
  • Mueller, Niklas, Klinikum der Universität München Medizinische Klinik und Poliklinik III, München, Bavaria, Germany
  • Müller, Sandra, Technische Universitat Wien Institut fur Diskrete Mathematik und Geometrie, Wien, Wien, Austria
  • Seibert, Felix S., Marienhospital Herne Medizinische Klinik I Innere Medizin, Herne, Nordrhein-Westfalen, Germany
  • Felderhoff, Thomas, Fachhochschule Dortmund, Dortmund, Nordrhein-Westfalen, Germany
  • Westhoff, Timm H., Marienhospital Herne Medizinische Klinik I Innere Medizin, Herne, Nordrhein-Westfalen, Germany

We recently demonstrated that pulse wave analysis may be useful in functional fistula monitoring using tonometric measurement. We now aimed to evaluate if convenient oscillometric devices are applicable to detect flow below 500 ml/min.


We recorded pulse waves ambilaterally with the vicorder® device at the brachial artery in 53 patients with native fistula and analyzed them with the use of a specifically developed matlab® application. The key parameters consisted of normalized variables assessed by the mean slope in the time sections between the footpoint, the systolic maximum (T1), the diacrotic notch, the first diastolic inflection point and the end of diastole: Specifically in the second section (slope2) and the sum of all four sections (slope). We furthermore assessed the amplitude of uncallibrated relative volumetric change in the measuring cuffs of the vicorder® device during cardiac cycle (AMP). Flow was measured with the use of duplex sonography.


There were marked differences in the wave contours of the fistula and non-fistula side (Figure 1). Medians (fistula/non-fistula) of slope2, slope∑ and AMP were -0.00150/-0.00322 [relative amplitude/ms, p < 0.001], 0.01094/0.01187 [relative amplitude/ms, p=0.006] and 1850/725 [relative volumetric change, p< 0.001] (Wilcoxon test of related samples). T1 was delayed at the fistula arm (204 ± 3.4 ms versus 162 ± 5.3 ms at the non-fistula arm, p<0.001). ROC-analyses of parameter values measured at the fistula arm to detect low flow fistula demonstrated AUCs (with CI) of 0.652 (0.437-0.866, p=0.167) for slope2, 0.732 (0.566-0.899, p=0.006) for slope∑ and 0.775 (0.56-0.991, p=0.012) for AMP (Figure 2).


Fistula functional monitoring with oscillometry is feasible and is a promising clinical application to detect a low flow fistula.

Clinical characteristics
NAgeBMIGenderFore/upper arm fistulaDiabetesPermanent AFCHDHFrEF
53 (100%)66±2.2 [years]25.6±0.6 [kg/m2 ]2.53 [m/f]2.3130 (56.6%)17 (32.1%)18 (34%)5 (9.4%)

Exemplary pulse waves at the fistula and non-fistula arm of one patient before and after treatment of fistula-stenosis.